Quintiles
Sales in Bloemfontein

Quintiles commercial group in South Africa is a leader in the country in outsourced contract sales services for the pharmaceutical industry.

To fully realize the commercial potential of biosimilars, you need to effectively address the distinct challenges and pressures involved: constantly evolving regulations, fierce competition, and market access are just a few. From concept to commercialization, you need a partner with the expertise, resources, and experience to manage the risks and accelerate your biosimilars clinical development. Biosimilars pose very different challenges than those presented by small molecule generics: higher costs and more demanding head to head similarity assessments: analytically, non-clinically and clinically: differences in regulatory framework in different markets can deter global investment; and a need for significant investments in sales and marketing. Our integrated solutions are designed to meet the distinct demands of bringing biosimilars to market and maximizing their ROI. We partner with all types of customers engaged in producing biologics, bio-betters and biosimilars. A global Biosimilars Center of Excellence (CoE) to provide thought leadership, guidance, and experience across the globe, including dedicated centers in the US and Asia Pacific. Extensive biosimilars experience, with over 50 phase I/III trials in various therapeutic areas. A streamlined operating model with regional service delivery to minimize costs and support your local needs. We help increase your potential for success by incorporating commercial and regulatory considerations early in the development process. We share your goals to accelerate launch without sacrificing quality, demonstrate safety and efficacy from initial phases to post-market, and build stakeholder trust. Our dedicated biosimilar intelligence team is ready to provide key regulatory, commercial and clinical insights to help your product realize its full potential. Healthcare systems and a variety of stakeholders are demanding convincing value data to show improved outcomes before approving new drugs. Quintiles combines strategic thinking with the ability to capture and analyze complex clinical data to effectively demonstrate real-world outcomes. With a clear understanding of your stakeholders’ requirements, you can start collecting the best data to demonstrate potential outcomes and engage with them to get their support prior to launch. Connecting clinical insight with commercialization experience. As healthcare systems become more complex and payers' influence becomes more prominent, Quintiles can help you create and implement an integrated market access strategy to successfully target your message, gain adoption on formularies, and negotiate better pricing and reimbursement. Our experts work with you during clinical development to map out appropriate disease profiles and plan market implementation. By understanding the diverse needs of all audiences, we collect the right kinds of evidence required to present compelling value and outcomes data to each stakeholder. This integrated approach enables you to confidently illustrate how your new product and desired pricing compares with existing treatments, which will help demonstrate the additional value of your drug. Throughout the process, you gain access to important data, key stakeholders and indispensable market awareness. This includes: A global network of regulatory experts sitting in-market, with existing relationships to decision makers in the healthcare system. Bringing the strategy to life: Exploring perspectives in patients centricity. Bringing the strategy to life: Exploring perspectives in outcomes. Bringing the strategy to life: Exploring perspectives in access. Bringing the strategy to life: Exploring perspectives of value.